714 related articles for article (PubMed ID: 19092805)
1. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.
Zhu L; Gibson P; Currle DS; Tong Y; Richardson RJ; Bayazitov IT; Poppleton H; Zakharenko S; Ellison DW; Gilbertson RJ
Nature; 2009 Jan; 457(7229):603-7. PubMed ID: 19092805
[TBL] [Abstract][Full Text] [Related]
2. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.
Snippert HJ; van Es JH; van den Born M; Begthel H; Stange DE; Barker N; Clevers H
Gastroenterology; 2009 Jun; 136(7):2187-2194.e1. PubMed ID: 19324043
[TBL] [Abstract][Full Text] [Related]
3. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
4. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas.
Holmberg Olausson K; Maire CL; Haidar S; Ling J; Learner E; Nistér M; Ligon KL
PLoS One; 2014; 9(9):e106694. PubMed ID: 25184684
[TBL] [Abstract][Full Text] [Related]
5. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
[TBL] [Abstract][Full Text] [Related]
6. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.
Schepers AG; Snippert HJ; Stange DE; van den Born M; van Es JH; van de Wetering M; Clevers H
Science; 2012 Aug; 337(6095):730-5. PubMed ID: 22855427
[TBL] [Abstract][Full Text] [Related]
7. Prominin 1/CD133 endothelium sustains growth of proneural glioma.
Ding BS; James D; Iyer R; Falciatori I; Hambardzumyan D; Wang S; Butler JM; Rabbany SY; Hormigo A
PLoS One; 2013; 8(4):e62150. PubMed ID: 23637986
[TBL] [Abstract][Full Text] [Related]
8. Crypt stem cells as the cells-of-origin of intestinal cancer.
Barker N; Ridgway RA; van Es JH; van de Wetering M; Begthel H; van den Born M; Danenberg E; Clarke AR; Sansom OJ; Clevers H
Nature; 2009 Jan; 457(7229):608-11. PubMed ID: 19092804
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue.
Becker L; Huang Q; Mashimo H
ScientificWorldJournal; 2008 Nov; 8():1168-76. PubMed ID: 19030762
[TBL] [Abstract][Full Text] [Related]
10. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomics on PROM1 gene encoding stem cell marker CD133.
Katoh Y; Katoh M
Int J Mol Med; 2007 Jun; 19(6):967-70. PubMed ID: 17487431
[TBL] [Abstract][Full Text] [Related]
12. Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland.
Anderson LH; Boulanger CA; Smith GH; Carmeliet P; Watson CJ
Dev Dyn; 2011 Mar; 240(3):674-81. PubMed ID: 21337465
[TBL] [Abstract][Full Text] [Related]
13. Fate of Prominin-1 Expressing Dermal Papilla Cells during Homeostasis, Wound Healing and Wnt Activation.
Kaushal GS; Rognoni E; Lichtenberger BM; Driskell RR; Kretzschmar K; Hoste E; Watt FM
J Invest Dermatol; 2015 Dec; 135(12):2926-2934. PubMed ID: 26288357
[TBL] [Abstract][Full Text] [Related]
14. Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance.
Montgomery RK; Shivdasani RA
Gastroenterology; 2009 Jun; 136(7):2051-4. PubMed ID: 19409288
[No Abstract] [Full Text] [Related]
15. Identification of stem cells in small intestine and colon by marker gene Lgr5.
Barker N; van Es JH; Kuipers J; Kujala P; van den Born M; Cozijnsen M; Haegebarth A; Korving J; Begthel H; Peters PJ; Clevers H
Nature; 2007 Oct; 449(7165):1003-7. PubMed ID: 17934449
[TBL] [Abstract][Full Text] [Related]
16. CD133 induces tumour-initiating properties in HEK293 cells.
Canis M; Lechner A; Mack B; Zengel P; Laubender RP; Koehler U; Heissmeyer V; Gires O
Tumour Biol; 2013 Feb; 34(1):437-43. PubMed ID: 23150174
[TBL] [Abstract][Full Text] [Related]
17. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
[TBL] [Abstract][Full Text] [Related]
18. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression.
Zhou L; Yu KH; Wong TL; Zhang Z; Chan CH; Loong JH; Che N; Yu HJ; Tan KV; Tong M; Ngan ES; Ho JW; Ma S
Gut; 2022 Aug; 71(8):1656-1668. PubMed ID: 34588223
[TBL] [Abstract][Full Text] [Related]
19. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts.
Leedham SJ; Rodenas-Cuadrado P; Howarth K; Lewis A; Mallappa S; Segditsas S; Davis H; Jeffery R; Rodriguez-Justo M; Keshav S; Travis SP; Graham TA; East J; Clark S; Tomlinson IP
Gut; 2013 Jan; 62(1):83-93. PubMed ID: 22287596
[TBL] [Abstract][Full Text] [Related]
20. Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.
Rappa G; Mercapide J; Anzanello F; Le TT; Johlfs MG; Fiscus RR; Wilsch-Bräuninger M; Corbeil D; Lorico A
Exp Cell Res; 2013 Apr; 319(6):810-9. PubMed ID: 23318676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
